HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
Breast Cancer: Targets and Therapy · 2026-06 · Volume 18 · 1-15
DOI: 10.2147/bctt.s612951 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-06. Verfasst von Hanxiao Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of the First Clinical Medicine, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of the First Clinical Medicine, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
- Department of Occupational Health, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
- Department of Breast Surgery, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
ORCID-Profile: Hanxiao Shi
Zitieren
APA
Shi, H., Feng, Y., Guo, T., Shou, W., & Li, Y. (2026). HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies. Breast Cancer: Targets and Therapy, Volume 18, 1-15. https://doi.org/10.2147/bctt.s612951
Vancouver
Shi H, Feng Y, Guo T, Shou W, Li Y. HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-15. doi:10.2147/bctt.s612951
BibTeX
@article{Shi2026,
author = {Shi, Hanxiao and Feng, Yiqian and Guo, Tao and Shou, Wenjun and Li, Yuandong},
title = {HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--15},
doi = {10.2147/bctt.s612951}
}
EUVIMED